SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1177My God, 10.7 mill short. Can't wait for the squeeze!Go Market Go!-5/25/2007
1176During the early days of Reg SHO it was easy to see how grandfathered short posiIRWIN JAMES FRANKEL-5/24/2007
1175>> Sure is a good thing we have the SEC and Reg SHO to protect us <<scaram(o)uche-5/24/2007
1174Reported Short Interest in millions Mar 8.9 Apr 8.8 May 10.7 (about 30% of oIRWIN JAMES FRANKEL-5/24/2007
1173Hi Jon, Balyasny had major stake in NFLD in November and early December. He ampgo-neil-5/23/2007
1172Do you know that big seller by any chance - i.e., reputation? Looks like the duRobohogs-5/23/2007
1171Institutional holdings should now be fairly complete for the quarter ending 3/31IRWIN JAMES FRANKEL-5/23/2007
1170Apparently they just did a non-deal roadshow in Europe last week. They must havRobohogs-5/23/2007
1169<i>In my view a cautious FDA is good for Momenta. It way reduces the chancDewDiligence_on_SI-5/22/2007
1168In my view a cautious FDA is good for Momenta. It way reduces the chances of mulBiomaven-5/22/2007
1167>>Questionable duplication, it's the best that's out there but we&IRWIN JAMES FRANKEL-5/22/2007
1166I don't see the avandia news having any bearing generic lovenox. The rest ofrkrw-5/21/2007
1165Interesting... My take away was Teva and Amphastar ANDA may fail with tougher FLJM-5/21/2007
1164IMO, the GSK/Avendia news today will not help MNTA's case before the FDA. ThArthur Radley-5/21/2007
1163"Tempo Pharmaceuticals is developing a proprietary nanoparticle technology Sidney Street-5/21/2007
1162In case anyone was wondering where Crane landed: polarisventures.comrkrw-5/21/2007
1161If one more analyst asks how mnta can work around first to file status :-) (if rkrw-5/21/2007
1160More on the generic-Copaxone story: investorshub.comDewDiligence_on_SI-5/20/2007
1159Bog off.nigel bates-5/19/2007
1158MNTA remains on the Reg SHO list as does, DNDN and NURO. I check the list most IRWIN JAMES FRANKEL-5/18/2007
1157FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type onigel bates-5/18/2007
1156Maybe the author was listening to that Buckinghams record from the 60s while wriDewDiligence_on_SI-5/17/2007
1155<i>With this launch, the company has become the first generic producer of tom pope-5/17/2007
1154Indian company launches generic Copaxone: pharmabiz.comDewDiligence_on_SI-5/17/2007
1153To see a face-off between rkrw and DD, I might just come. :-) ijIRWIN JAMES FRANKEL-5/16/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News